(CNN) — The U.S. Food and Drug Administration has approved a new cholesterol lowering medication.
Esperion’s Nexletol is a once-daily tablet that is an alternative for millions of patients that can’t take or don’t respond well to statins.
The company says it’s the first oral non-statin drug approved in nearly two decades.
During studies, the drug reduced cholesterol in patients by an average of 18-percent when used with moderate or high intensity statins.
The new drug could become available as early as late March.
More from MyHighPlains.com:
- US advisers endorse single-shot COVID-19 vaccine from J&J
- Merrick Pet Care launches largest advertising campaign in 30 years
- Immigration correspondent discuss latest update on migrants crossing from refugee camps
- Full Snow Moon is this weekend, and you can see 3 planets at sunrise
- Not real: A look at the fake news circulating on social media this week